What does CUSIP 03237H101 represent in this 13F holders report?

CUSIP 03237H101 is the security identifier for AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock in Q1 2024?

138 institutional investors reported AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock for Q1 2024. Use the holders table for investor-level position and value details.

Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

CUSIP: 03237H101

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock
Shares outstanding: 109,540,561
Total 13F shares: 49,485,594
Share change: -10,827,488
Total reported value: $140,539,742
Put/Call ratio: 35%
Price per share: $2.84
Number of holders: 138
Value change: -$234,955,037
Number of buys: 79
Number of sells: 106

Quarterly Holders Quick Answers

What is CUSIP 03237H101?
CUSIP 03237H101 identifies AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 03237H101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ALS Invest 1 B.V.	3/4/5	10%+ Owner	— class O/S missing	5,895,280	$96,258,721	—	06 Jul 2022	3/4/5
Morningside Venture Investments Ltd	3/4/5	10%+ Owner	— class O/S missing	4,997,302	$81,596,447	—	15 Aug 2023	3/4/5
VANGUARD GROUP INC	13F	Company	4.8%	5,275,566	$77,656,332	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	3.7%	4,002,334	$58,914,357	—	31 Dec 2023	13F
VIKING GLOBAL INVESTORS LP	13F 3/4/5	Company · 10%+ Owner	2.7%	2,962,555	$43,608,810	—	31 Dec 2023	13F 3/4/5
MORGAN STANLEY	13F	Company	2.6%	2,830,243	$41,661,177	—	31 Dec 2023	13F
Point72 Asset Management, L.P.	13F	Company	2.5%	2,751,305	$40,499,210	—	31 Dec 2023	13F
DRAGSA 96 LLC	3/4/5	10%+ Owner	— class O/S missing	2,300,000	$37,554,630	—	11 Jan 2022	3/4/5
Stonepine Capital Management, LLC	13F	Company	2.3%	2,500,000	$36,800,000	—	31 Dec 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.1%	2,272,643	$33,453,305	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	2%	2,240,885	$32,985,827	—	31 Dec 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.7%	1,869,125	$27,513,520	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	1.3%	1,441,402	$21,217,437	—	31 Dec 2023	13F
FMR LLC	13F	Company	1.3%	1,436,151	$21,140,143	—	31 Dec 2023	13F
FRANKLIN RESOURCES INC	13F	Company	1.2%	1,325,001	$19,504,015	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.1%	1,256,861	$18,500,994	—	31 Dec 2023	13F
JANE STREET GROUP, LLC	13F	Company	1.1%	1,157,165	$17,033,469	—	31 Dec 2023	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1%	1,116,837	$16,439,841	—	31 Dec 2023	13F
Saturn V Capital Management LP	13F	Company	1%	1,099,268	$16,181,225	—	31 Dec 2023	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.97%	1,060,900	$15,616,448	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.94%	1,030,716	$15,173,546	—	31 Dec 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.93%	1,021,657	$15,038,791	—	31 Dec 2023	13F
MARSHALL WACE, LLP	13F	Company	0.9%	985,114	$14,500,879	—	31 Dec 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.82%	894,780	$13,172,000	—	31 Dec 2023	13F
Ikarian Capital, LLC	13F	Company	0.8%	877,500	$12,916,799	—	31 Dec 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.78%	853,000	$12,556,160	—	31 Dec 2023	13F
Alpha Wave Global, LP	13F	Company	0.77%	846,240	$12,456,653	—	31 Dec 2023	13F
EMERALD ADVISERS, LLC	13F	Company	0.73%	802,610	$11,814,413	—	31 Dec 2023	13F
GMT CAPITAL CORP	13F	Company	0.72%	786,000	$11,569,920	—	31 Dec 2023	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.6%	656,530	$9,664,122	—	31 Dec 2023	13F
Nantahala Capital Management, LLC	13F	Company	0.57%	620,110	$9,128,019	—	31 Dec 2023	13F
Walleye Capital LLC	13F	Company	0.53%	582,728	$8,577,756	—	31 Dec 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.51%	562,940	$8,286,477	—	31 Dec 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.5%	546,965	$8,051,325	—	31 Dec 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.5%	542,546	$7,986,286	—	31 Dec 2023	13F
Rock Springs Capital Management LP	13F	Company	0.49%	535,012	$7,875,377	—	31 Dec 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.46%	503,672	$7,414,052	—	31 Dec 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.44%	482,599	$7,103,857	—	31 Dec 2023	13F
Woodline Partners LP	13F	Company	0.43%	470,801	$6,930,191	—	31 Dec 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.42%	465,445	$6,851,350	—	31 Dec 2023	13F
Hudson Bay Capital Management LP	13F	Company	0.42%	460,600	$6,780,032	—	31 Dec 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.4%	436,835	$6,430,211	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.4%	435,437	$6,409,633	—	31 Dec 2023	13F
CITIGROUP INC	13F	Company	0.35%	387,664	$5,706,414	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.35%	387,620	$5,705,766	—	31 Dec 2023	13F
Margaret Olinger	3/4/5	Chief Commercial Officer	— mixed-class rows	320,685 mixed-class rows	$5,178,792	—	27 Dec 2023	3/4/5
DARK FOREST CAPITAL MANAGEMENT LP	13F	Company	0.29%	312,463	$4,599,455	—	31 Dec 2023	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.27%	295,000	$4,342,400	—	31 Dec 2023	13F
Ally Bridge Group (NY) LLC	13F	Company	0.25%	275,773	$4,059,379	—	31 Dec 2023	13F
Trexquant Investment LP	13F	Company	0.24%	265,046	$3,901,477	—	31 Dec 2023	13F

Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) as of Q1 2024

As of 31 Mar 2024, Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,485,594 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, STATE STREET CORP, FRANKLIN RESOURCES INC, Boxer Capital, LLC, TWO SIGMA INVESTMENTS, LP, and CITADEL ADVISORS LLC. This page lists 138 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

177

Q1 2024 holders

138

Holder diff

-39

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.